The Institute for OneWorld Health has discovered that addressing the world’s most menacing health threats sometimes means leaving money on the table. The organization, which is the nation’s first nonprofit pharmaceutical company, develops medications to tackle diseases in the developing world. Because drug development can take as many as 10 years from drawing board to regulatory approval, OneWorld Health has chosen to focus solely on its mission.
After the Asian tsunami, though, wealthy donors...
To read this article and start a full year of unlimited online access, subscribe now!Subscribe Now
Already a subscriber?Login
Need to register for your premium online access,which is included with your paid subscription?Register Now